Navigation Links
bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results
Date:11/20/2008

Company Experiences Record Revenue Growth from Operations in Third Quarter

JERICHO, N.Y., Nov. 19 /PRNewswire-FirstCall/ -- bioMETRX, Inc. (OTC Bulletin Board: BMRX), a leading developer of consumer-based finger recognition products, today announced its financial results for the period ending September 30, 2008.

-- Revenues for the third quarter were $431,840, which represents a 430% increase over second quarter revenues of $100,000.

-- The Company added $300,000 of intangible assets to its balance sheet as a result of the Sequiam asset purchase.

"We have seen a steady increase in sales of our products over the last three months. Today, economic concerns trouble consumers and retailers report dramatic downturns in consumer spending; however, we are seeing a surge in sales of our products that protect consumer valuables and are priced right," noted Kevin Henderson, Senior V.P. at bioMETRX.

"We are extremely pleased with the response we have received to our products," stated Lorraine Yarde, Chief Operating Officer at bioMETRX. "With the holidays approaching, we expect to see sales of our safe products increase as consumers look for innovative yet practical gifts for family and friends. The previously announced sales and marketing initiatives are scheduled to coordinate with new retail channels for all of the company's products. These initiatives are being designed to increase the market's awareness of our products to drive more revenue," Ms. Yarde went on to say.

About bioMETRX, Inc.

bioMETRX, Inc. designs, develops and markets biometrics-based products to the consumer market under the common brand name - smartTOUCH(TM). As the global leader in consumer biometric product engineering, development and sales, bioMETRX's smartTOUCH(TM) technology has proven to be the most dependable and robust consumer biometric pla
'/>"/>

SOURCE bioMETRX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. bioMETRX, Inc. Calls Series B Warrants
2. bioMETRX, Inc. Acquires Patent for Biometric Padlock
3. bioMETRX, Inc. Acquires Patent for Biometric Padlock
4. bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line
5. bioMETRX, Inc. Closes Angel Round of Funding
6. bioMETRX, Inc. Introduces New Products
7. bioMETRX, Inc. Files for Several New Patents
8. bioMETRX, Inc. Garage Door Opener Named Best In Class
9. bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology
10. bioMETRX, Inc. Gun Storage Products Endorsed by the Handgun Club of America
11. bioMETRX, Inc. Completes Sequiam Asset Purchase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...i Smith, Ph.D., an assistant professor of patholog...as Health Science Center at Houston, has received ...hilia Foundation. , The award will support Smit... people with Hemophilia A, a bleeding disorder, wh...ophilia A affects about one in every 5,000 males b...
(Date:7/1/2009)...dly diseases including plague, Ebola and Rift Vall...-million pound international partnership involving...Development Centre (LIDC). The Southern African Ce...links medical and veterinary institutions from fiv...city of African institutions to detect, identify a...
(Date:7/1/2009)...esearchers from the Department of Science Educatio...anaged to make out the "self-irrigating" mechanism...t 16 times the amount of water than otherwise expe...ities of rain in the desert. This is the first exa... desert rhubarb grows in the mountains of Israel,s...
(Date:7/1/2009)...entists have uncovered new evidence suggesting tha...lerosis accumulates because the body,s natural mec...lin" stalls out. , The study, published today, ...velopment ," was conducted by scientists at the Un...ty of Cambridge. The research was led by co-senior...
Breaking Biology News(10 mins):UT scientist receives hemophilia research award 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 3Desert rhubarb -- a self-irrigating plant 2MS study offers theory for why repair of brain's wiring fails 2MS study offers theory for why repair of brain's wiring fails 3Marketing Executives Finding Value in Best Practice Database 18184 1Marketing Executives Finding Value in Best Practice Database 18184 2Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing 5040 1Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing 5040 2Phyhealth Appoints Gerald H Priceman as Medical Director 18179 1Phyhealth Appoints Gerald H Priceman as Medical Director 18179 2Phyhealth Appoints Gerald H Priceman as Medical Director 18179 3Former GE Kodak and SGS Executive Dan Kerpelman to Join Bio Optronics as President and CEO 5039 1Former GE Kodak and SGS Executive Dan Kerpelman to Join Bio Optronics as President and CEO 5039 2
... by investigators at Washington University School ...riant for a bitter-taste receptor on the tongue is...endence.The research team studied DNA samples from...coholic individuals. The families are participatin...dy of the Genetics of Alcoholism (COGA). COGA inve...
...stern Medical Center shows that on a biochemical l...nematodes work similarly to the way in which certa...may help eradicate worm infections that afflict a ... researchers have discovered a molecule that activ...ction of Caenorhabditis elegans, a common research...
...totillers, female salmon can industriously churn u...re than once, using just their tails. , For decade...g triggered only local effects. But a University o...Science journal that the silt, minerals and nutrie... causing changes in rivers and lakes far from the ...
...important model organisms for molecular science to...h the most is known. The genes of higher-level pla... by their similarity to E. coli genes. As such, t...rmation is of great importance to the scientific c...orts of scientists working independently on the ge...
Other Biology News:Variation in bitter-taste receptor gene increases risk for alcoholism 2Worm hormone discovery may aid fight against parasitic disease 2Worm hormone discovery may aid fight against parasitic disease 3Leave it to salmon to leave no stone unturned 2Leave it to salmon to leave no stone unturned 3MBL leads effort to update E. coli genome 2
(Date:7/1/2009)...re/ -- Johnson & Johnson today announced t...t of Molecular Biology at the Max Planck Institute...e led to novel cancer therapies including Hercepti... Paul Janssen Award for Biomedical Research. An in...elected Dr. Ullrich, who on September 8 will recei...
(Date:7/1/2009)...tional sustained follicle stimulant achieves simil...a given over a one week period in Phase III Study ... Schering-Plough Corp., (NYSE: SGP ) today annou...ial demonstrating that a single injection of corif...ollicle stimulants, achieved similar efficacy to r...
(Date:7/1/2009)...y 1 Human Genome Scienc... expects to have top-line results available on Mon...tal Phase 3 clinical trials of BENLYSTA(TM) (belim...erythematosus (SLE). , , (Logo: http://www... , Senior management will host a conference call...
(Date:6/30/2009)...DUSTRY, Calif. and HONG KONG, June 30 /PRNewswire-...ets: EFTB), announced today that Excalibur,s Ocean...wan Strait passenger voyage which has been highlig...ites, including the Taiwan Sun, and the Qatar Trib...y launched a cruise service with China on Sunday, ...
Breaking Biology Technology:Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 3Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 2Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 3
... Milwaukee, Wis. - By several measures, these sho...r a recession in which two million manufacturing j...revenue is back, and new orders are back. , ,Yet ...petitive pressure from China, where wage earners m...arn, where manufacturers have a 10 percentage poin...
... The model is that the ownership of a patent righ... rights to inventions made in the workplace? The c...circumstances. , ,A first question to be asked: Is...yee that includes the obligation to assign all inv... , ,No? Then you must ask: Was the employee hired ...
... Madison, Wis. - The Wisconsin Angel Network , h...ntations, has launched its new ePlan system to ena... video presentations for would-be investors. , ,Th...ic Foundry , is designed to help companies reach m...out the cost of an airplane ticket, businesses see...
... In our last encounter, we reviewed the list of t...d you, at that time, that we would look at some of... 2005. , ,Let,s get to it: , Leading Global Phar...se Area Sales ($billions) % Growth 1. Li... 2. Plavix (Bristol-Myers Squibb) Anti-coagulan...
Other Biology Technology:Manufacturers advised to redesign customer relations 2Manufacturers advised to redesign customer relations 3Who owns what invention in the workplace? 2Angel network introduces ePlan 2Big Pharma's continued hunger and search for new products 2Big Pharma's continued hunger and search for new products 3Big Pharma's continued hunger and search for new products 4
Custom siRNA, PAGE purified from Ambion
Silencer In Vivo Ready siRNAs from Ambion
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
Combination Roto Shake Genie from Femto Scientific
Biology Products: